Texas Brings COVID-19 Therapeutic Infusion Center to El Paso

The Texas Department of State Health Services (DSHS) announced today it is launching a new COVID-19 therapeutic infusion center in El Paso. This innovative treatment is available at no cost to the patient.

COVID-19 antibody infusion treatment can prevent a patient's condition from worsening and requiring hospital care.

The El Paso infusion center will begin accepting patients today and has been provided with the REGEN-COV monoclonal antibodies to treat outpatient cases of COVID-19 who have a referral from a doctor.

Regeneron's REGEN-COV Anti-SARS-CoV-2 Monoclonal Antibody treatment combines two monoclonal antibodies, casirivimab, and imdevimab, explicitly designed to block the infectivity of the SARS-CoV-2 betacoronavirus that causes COVID-19.

Texas Governor Abbott stated in a media statement, "I thank DSHS for continuing to work alongside local partners in communities across the state to establish these facilities where they are needed most." 

Texas began deploying similar measures in November 2020.

DSHS and other departments have established and expanded these facilities to increase bed capacity in local hospitals so that resources are available for the illest patients.
 
These state-sponsored Infusion Centers are in addition to the antibody infusion treatments provided by more than 200 private health providers across the state. 

Texans can visit meds.tdem.texas.gov to find a therapeutic provider near them.